Text Size

Patient Expectations After Implantable-cardioverter Defibrillator (ICD) Implantation

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Rita Redberg, University of California, San Francisco
ClinicalTrials.gov Identifier:
NCT00845390
First received: February 17, 2009
Last updated: April 26, 2012
Last verified: April 2012
History of Changes
  Purpose

This study will be a qualitative survey to understand the expectations of defibrillator patients with regards to their device. It is unknown what ICD (implantable-cardioverter defibrillator) patients understand about their device and its purpose, thus we will be talking to them about their device. Also, we will be interested in studying their beliefs on how the ICD impacts their life expectancy and quality of life.


Condition
Defibrillators, Implantable

Study Type: Observational
Study Design: Observational Model: Case Control
Official Title: Patient Expectations After ICD Implantation

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by University of California, San Francisco:

Primary Outcome Measures:
  • Why did you have an ICD implanted? [ Time Frame: after ICD implantation ] [ Designated as safety issue: No ]

Enrollment: 100
Study Start Date: December 2008
Study Completion Date: August 2009
Primary Completion Date: August 2009 (Final data collection date for primary outcome measure)
Groups/Cohorts
ICD Patients
ICD patients

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

ICD Clinic patients

Criteria

Inclusion Criteria:

  • All patients are eligible for inclusion. We hope to acquire a wide range of ages but are not limited to a specific set.

Exclusion Criteria:

  • Non-English speakers will be excluded.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00845390

Locations
United States, California
UCSF Arrhythmia and Device Clinic
San Francisco, California, United States, 94143
Sponsors and Collaborators
University of California, San Francisco
Investigators
Principal Investigator: Rita F Redberg, M.D. University of California, San Francisco
  More Information

No publications provided

Responsible Party: Rita Redberg, M.D., M.Sc., F.A.C.C., University of California, San Francisco
ClinicalTrials.gov Identifier: NCT00845390     History of Changes
Other Study ID Numbers: CHR #08033561
Study First Received: February 17, 2009
Last Updated: April 26, 2012
Health Authority: United States: Institutional Review Board

ClinicalTrials.gov processed this record on May 19, 2013